Nasdaq Stockholm AB has assessed that Karo Pharma, company registration number 556309-3359, fulfills Nasdaq First North Growth Market's listing requirements. Provided that Karo Pharma, applies for admission to trading of its shares on Nasdaq First North Growth Market Sweden, first day of trading is expected to be March 25, 2022. Short name: KARO ----------------------------------------------- Number of shares: 225033204 ----------------------------------------------- ISIN code: SE0007464XXX ----------------------------------------------- Round Lot: 1 ----------------------------------------------- Order book ID: 3927 ----------------------------------------------- Company Registration Number: 556309-3359 ----------------------------------------------- Market segment: First North STO/8 ----------------------------------------------- Tick Size table: Other Equities ----------------------------------------------- Trading currency: SEK ----------------------------------------------- This information is distributed at the request of the Certified Adviser, Erik Penser Bank. For further information, please call Erik Penser Bank on +4684638300.
© 2022 GlobeNewswire
